The FDA approved Fayuvi, impacting Ultragenyx Pharmaceutical's 2027 financial targets.
The FDA approved Fayuvi.
economy2 h ago
Yahoo FinanceRead original ↗
Biopharmaceutical company based in Novato, California, United States
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need.
Source: Wikipedia (CC BY-SA)The FDA approved Fayuvi.